tiprankstipranks
Cynata Therapeutics Limited (AU:CYP)
:CYP
Australian Market

Cynata Therapeutics Limited (CYP) Financial Statements

Compare
6 Followers

Cynata Therapeutics Limited Financial Overview

Cynata Therapeutics Limited's market cap is currently AU$46.31M. The company's EPS TTM is AU$-0.054; its P/E ratio is ―; Cynata Therapeutics Limited is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -13.84M$ -9.08M$ -10.51M$ -10.06M$ -6.13M
EBITDA$ -13.56M$ -8.80M$ -10.23M$ -9.78M$ -5.85M
Net Income$ -5.45M$ -7.69M$ -3.64M$ -8.47M$ -4.57M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 26.55M$ 29.97M$ 17.48M$ 12.25M$ 16.13M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -23.80M$ -26.72M$ -13.65M$ -6.98M$ -12.21M
Total Liabilities$ 2.59M$ 1.60M$ 689.74K$ 1.28M$ 746.15K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -3.30M$ -5.16M$ -3.39M$ -6.76M$ -4.06M
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

Cynata Therapeutics Limited Earnings and Revenue History

Cynata Therapeutics Limited Debt to Assets

Cynata Therapeutics Limited Cash Flow

Cynata Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis